About Tyra Biosciences, Inc. - Common Stock (TYRA)
Tyra Biosciences is a biotechnology company focused on developing innovative therapies for patients with genetically defined cancers. By harnessing advanced protein modulation technologies, the company aims to create targeted treatments that address specific genetic drivers of cancer, improving the efficacy and safety of therapies for individuals with unmet medical needs. Through its commitment to precision medicine, Tyra seeks to transform the landscape of cancer care by advancing drug candidates through clinical development and fostering collaborations within the scientific community. Read More
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tyra Biosciences, Inc. (“Tyra” or the “Company”) (NASDAQ: TYRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
